Related Experiment Videos

Novel anticoagulant agents: introduction

S Schulman1

  • 1Department of Medicine, Coagulation Unit, Division of Hematology, Karolinska Hospital, Stockholm, Sweden. sam.schulman@ks.se

Journal of Internal Medicine
|September 17, 2003
PubMed

Insights

This review covers anticoagulant therapy principles and novel selective coagulation inhibitors in clinical trials. It explores mechanisms of action, and effects on inflammation and cancer.

Area of Science:

  • Pharmacology
  • Hematology
  • Oncology

Background:

  • Anticoagulant therapy is crucial for managing thrombotic disorders.
  • Novel anticoagulants offer targeted mechanisms with potentially improved safety profiles.
  • Emerging research suggests links between coagulation, inflammation, and cancer.

Purpose of the Study:

  • To discuss fundamental principles of anticoagulant therapy.
  • To introduce novel, selective coagulation inhibitors in advanced clinical trials.
  • To provide a broad overview of their mechanisms of action, including effects on inflammation and cancer.

Main Methods:

  • Review of current literature on anticoagulant therapy.
  • Discussion of principles guiding anticoagulant drug development.
  • Analysis of data from advanced clinical trials of novel inhibitors.

Main Results:

  • Identification of key principles for effective anticoagulant therapy.
  • Presentation of several selective coagulation inhibitors nearing clinical application.
  • Exploration of the multifaceted roles of coagulation factors beyond hemostasis.

Conclusions:

  • Novel anticoagulants represent a significant advancement in thrombotic disorder management.
  • Understanding coagulation mechanisms is vital for developing targeted therapies.
  • Coagulation pathways are increasingly recognized for their roles in inflammation and cancer progression.

Related Concept Videos